InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: sts66 post# 29629

Saturday, 06/21/2014 1:36:44 PM

Saturday, June 21, 2014 1:36:44 PM

Post# of 426487
STS, I hope you remember ACCORD and AIM-HIGH trial patients' medium TG level is quite healthy. However, the high TG subgroup of trial patients did show a CV benefit of over 33%
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News